| Secondary |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
14.7% |
| Hypertension |
14.4% |
| Angina Pectoris |
8.7% |
| Cardiac Failure |
4.6% |
| Type 2 Diabetes Mellitus |
3.8% |
| Prophylaxis |
3.3% |
| Diabetes Mellitus |
3.0% |
| Arrhythmia |
2.7% |
| Acute Myocardial Infarction |
2.2% |
| Atrial Fibrillation |
2.2% |
| Depression |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hypokalaemia |
2.2% |
| Essential Hypertension |
1.9% |
| Lung Neoplasm Malignant |
1.9% |
| Back Pain |
1.4% |
| Dementia Alzheimer's Type |
1.4% |
| Sleep Disorder |
1.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.1% |
|
| Haematoma |
14.7% |
| Sudden Death |
9.3% |
| Renal Failure Acute |
8.0% |
| Thrombocytopenia |
8.0% |
| Vertigo |
8.0% |
| Malaise |
5.3% |
| Renal Failure |
5.3% |
| Aphthous Stomatitis |
4.0% |
| Fall |
4.0% |
| Lactic Acidosis |
4.0% |
| Tricuspid Valve Disease |
4.0% |
| Visual Impairment |
4.0% |
| Weight Decreased |
4.0% |
| Leukopenia |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Overdose |
2.7% |
| Pancytopenia |
2.7% |
| Skin Ulcer |
2.7% |
| Syncope |
2.7% |
| Anaemia Haemolytic Autoimmune |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.6% |
| Drug Use For Unknown Indication |
17.1% |
| Hypertension |
14.5% |
| Unevaluable Event |
9.9% |
| Renal Transplant |
5.0% |
| Prophylaxis |
3.5% |
| Lung Infection |
2.8% |
| Ill-defined Disorder |
2.5% |
| Transplant Rejection |
2.4% |
| Arteriosclerosis Obliterans |
2.1% |
| Diabetes Mellitus |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Depression |
2.0% |
| Epilepsy |
1.9% |
| Pain |
1.9% |
| Arteriosclerosis |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Angina Pectoris |
1.7% |
| Asthma |
1.7% |
| Cardiac Disorder |
1.7% |
|
| Renal Failure Acute |
15.0% |
| Thrombocytopenia |
10.5% |
| Somnolence |
8.3% |
| Vomiting |
7.5% |
| Rhabdomyolysis |
6.8% |
| Weight Decreased |
5.3% |
| Gastrointestinal Haemorrhage |
4.5% |
| Pyrexia |
4.5% |
| Infarction |
3.8% |
| Wound Dehiscence |
3.8% |
| Anaemia |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Haematoma |
3.0% |
| Haemolytic Anaemia |
3.0% |
| Proctalgia |
3.0% |
| Renal Impairment |
3.0% |
| Shock |
3.0% |
| Syncope |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
| Toxic Skin Eruption |
3.0% |
|
| Interacting |
| Ill-defined Disorder |
64.5% |
| Angina Pectoris |
9.7% |
| Arrhythmia |
6.5% |
| Essential Hypertension |
6.5% |
| Hypertension |
6.5% |
| Prophylaxis |
6.5% |
|
| Vertigo |
66.7% |
| Traumatic Haematoma |
33.3% |
|
